JP2017512189A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512189A5
JP2017512189A5 JP2016551833A JP2016551833A JP2017512189A5 JP 2017512189 A5 JP2017512189 A5 JP 2017512189A5 JP 2016551833 A JP2016551833 A JP 2016551833A JP 2016551833 A JP2016551833 A JP 2016551833A JP 2017512189 A5 JP2017512189 A5 JP 2017512189A5
Authority
JP
Japan
Prior art keywords
composition
silicate
stabilized
aspects
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016551833A
Other languages
English (en)
Japanese (ja)
Other versions
JP6618475B2 (ja
JP2017512189A (ja
Filing date
Publication date
Priority claimed from GB201402672A external-priority patent/GB201402672D0/en
Application filed filed Critical
Publication of JP2017512189A publication Critical patent/JP2017512189A/ja
Publication of JP2017512189A5 publication Critical patent/JP2017512189A5/ja
Application granted granted Critical
Publication of JP6618475B2 publication Critical patent/JP6618475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016551833A 2014-02-14 2015-02-13 安定化されたポリマーのケイ酸塩組成物に関係する物質及び方法 Active JP6618475B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201402672A GB201402672D0 (en) 2014-02-14 2014-02-14 Materials and methods relating to stabilised polymeric silicate compositions
GB1402672.8 2014-02-14
PCT/GB2015/050409 WO2015121666A1 (en) 2014-02-14 2015-02-13 Materials and methods relating to stabilised polymeric silicate compositions

Publications (3)

Publication Number Publication Date
JP2017512189A JP2017512189A (ja) 2017-05-18
JP2017512189A5 true JP2017512189A5 (cg-RX-API-DMAC7.html) 2018-03-29
JP6618475B2 JP6618475B2 (ja) 2019-12-11

Family

ID=50440204

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551833A Active JP6618475B2 (ja) 2014-02-14 2015-02-13 安定化されたポリマーのケイ酸塩組成物に関係する物質及び方法

Country Status (13)

Country Link
US (4) US20170042934A1 (cg-RX-API-DMAC7.html)
EP (1) EP3105281B1 (cg-RX-API-DMAC7.html)
JP (1) JP6618475B2 (cg-RX-API-DMAC7.html)
KR (1) KR102354909B1 (cg-RX-API-DMAC7.html)
CN (1) CN106164136B (cg-RX-API-DMAC7.html)
AU (1) AU2015216711B2 (cg-RX-API-DMAC7.html)
CA (1) CA2939419C (cg-RX-API-DMAC7.html)
EA (1) EA034577B1 (cg-RX-API-DMAC7.html)
ES (1) ES2872498T3 (cg-RX-API-DMAC7.html)
GB (1) GB201402672D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ723746A (cg-RX-API-DMAC7.html)
SG (2) SG10202000307VA (cg-RX-API-DMAC7.html)
WO (1) WO2015121666A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3939599A3 (en) 2007-10-15 2022-03-16 HS Pharmaceuticals, LLC Silicate containing compositions and methods of treatment
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
WO2017173317A1 (en) * 2016-04-01 2017-10-05 Nickels Daniel Novel bone putty compositions and methods of use thereof
US10604257B2 (en) * 2016-06-28 2020-03-31 International Business Machines Corporation Unmanned aerial vehicle for air sampling
US11007217B2 (en) 2016-08-10 2021-05-18 United Kingdom Research And Innovation Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
KR20180034937A (ko) 2016-09-28 2018-04-05 모멘티브퍼포먼스머티리얼스코리아 주식회사 유기 전자 소자 봉지재용 조성물 및 이를 이용하여 형성된 봉지재
GB201701944D0 (en) * 2017-02-06 2017-03-22 Medical Res Council Antimicrobial compositions and their uses
KR102427987B1 (ko) 2018-11-27 2022-08-02 주식회사 엘지화학 전가수분해된 폴리실리케이트의 합성방법
WO2020218834A1 (ko) * 2019-04-24 2020-10-29 윤종오 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
KR102207608B1 (ko) * 2019-04-24 2021-01-26 윤종오 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
AU2020405124A1 (en) * 2019-12-20 2022-08-04 Veri Nano Inc. Nanostructured binary gel composition and use thereof
WO2025178550A1 (en) * 2024-02-22 2025-08-28 Lea Cares Ab Method to form supernatant
SE2450523A1 (en) * 2024-02-22 2025-08-23 Lea Cares Ab Method to form supernatant

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1688228A (en) 1928-10-16 gebmany
US4029770A (en) 1974-03-26 1977-06-14 Caw Industries, Inc. Method of therapeutically treating damaged and/or infected tissue and relieving stress and shock in warm blooded animals
US4563351A (en) 1983-08-01 1986-01-07 Forsyth Dental Infirmary For Children Self-gelling therapeutic compositions for topical application
US5080900A (en) 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash
HUT73791A (en) 1992-11-06 1996-09-30 H E Stanley Pharmaceuticals Compositions of oak bark extract, related synthetic compositions, and method of using same
US7014870B1 (en) 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
US5370876A (en) 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
JP2588109B2 (ja) 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
NL9400189A (nl) 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
US20060246154A1 (en) 1997-10-08 2006-11-02 Hon David N Composition of oak bark extract, related synthetic compositions, and method of using same
FR2799758B1 (fr) 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
CA2298762C (en) 2000-02-11 2001-06-12 Paul M. Pidcock Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections
KR100330993B1 (ko) 2000-02-18 2002-04-01 김승일 액상 사료 첨가제 및 이의 제조방법
RU2182006C2 (ru) 2000-03-01 2002-05-10 Цивинский Станислав Викторович Способ лечения ревматоидного артрита
US6692775B2 (en) 2000-03-13 2004-02-17 Aqua Med, Inc. Bactericidal gel and method for treating burns and dermal lesions
US6288045B1 (en) 2000-06-09 2001-09-11 Lifelink Pharmaceuticals, Inc. Epithelial cell cancer drug
KR100331952B1 (ko) 2000-11-23 2002-04-09 최수일 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도
US20040057958A1 (en) 2002-05-17 2004-03-25 Waggoner David W. Immunogenicity-enhancing carriers and compositions thereof and methods of using the same
ATE361267T1 (de) 2002-05-31 2007-05-15 Sabalo N V Wässrige lösung von nicht-kolloid-kieselsäure und borsäure
WO2004017913A2 (en) 2002-08-22 2004-03-04 Nutrition 21, Inc. Arginine silicate inositol complex and use thereof
RU2237483C1 (ru) 2003-02-21 2004-10-10 Цивинский Станислав Викторович Средство для лечения гастрита с повышенной кислотностью и язвенной болезни и способ их лечения
BR0318593A2 (pt) 2003-05-15 2009-03-10 Rahul Kanumuru Raju silicatos de metais de transiÇço funcionais (ftms)
CN100366534C (zh) * 2004-05-09 2008-02-06 中国石化北京燕化石油化工股份有限公司 适用于阴离子聚合的层状硅酸盐的改性方法、由此得到的改性层状硅酸盐及其用途
CN1315484C (zh) 2004-11-16 2007-05-16 关相龙 治疗皮肤病的药物载体组合物及制备方法
RU2280458C1 (ru) 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
DE102004063599B4 (de) 2004-12-30 2007-07-12 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese
NZ537747A (en) 2005-01-18 2008-02-29 Victoria Link Ltd Nano-structured silicate, functionalised forms thereof, preparation and uses
CA2604751A1 (en) 2005-04-20 2006-12-28 Laboratoires Mauves Inc. Organic silicic acids complex for therapeutic and cosmetic applications
US20070161539A1 (en) * 2006-01-12 2007-07-12 Enrique Hernandez Method of regulating degree of polymerization of an alkali metal silicate in solution using pH
CA2673313A1 (en) 2006-12-18 2008-12-04 Amcol International Virus-interacting layered phyllosilicates and methods of use
US20100278935A1 (en) 2007-07-30 2010-11-04 Stacey William C Immune System Modulator Formulation
EP3939599A3 (en) 2007-10-15 2022-03-16 HS Pharmaceuticals, LLC Silicate containing compositions and methods of treatment
WO2009114087A2 (en) 2008-03-03 2009-09-17 Luna Innovations Incorporated A method for treating pruritus by administering fullerenes
WO2009127256A1 (en) * 2008-04-17 2009-10-22 Jisbrey, S.A Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use
EP2151466A1 (en) * 2008-08-01 2010-02-10 SiNatur GmbH Biologically active silicic acid
EP2371220B2 (en) * 2010-03-31 2018-01-17 Taminco Stabilized bio-available soluble silicate solution
CA2852210C (en) * 2010-10-26 2019-04-02 Quinnova Pharmaceuticals, Inc. Composition and method for treating wounds
GB201402669D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Stabilised silicate compositions and their uses

Similar Documents

Publication Publication Date Title
JP2017512189A5 (cg-RX-API-DMAC7.html)
US20210128641A1 (en) Compositions and methods for treating skin and mucous membrane diseases
JP6618475B2 (ja) 安定化されたポリマーのケイ酸塩組成物に関係する物質及び方法
JP7716122B2 (ja) プロバイオティクス体系及びその応用
RU2015103826A (ru) Микрочастица (варианты), ее включающая композиция (варианты), пищевой, фармацевтический, лечебный косметический или нутрицевтический продукт на их основе, способ приготовления иммуномодулирующей композиции с их помощью и способ получения указанной микрочастицы
JP2013511557A5 (cg-RX-API-DMAC7.html)
JP2012522018A5 (cg-RX-API-DMAC7.html)
WO2015149944A3 (en) Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
WO2015162570A1 (en) Topical composition for use in the treatment of inflammatory bowel disease
JP2015512386A5 (cg-RX-API-DMAC7.html)
WO2017208172A1 (en) Bacteria-based gel compositions for topical applications and uses thereof
CN105726487A (zh) 一种高含量阿莫西林可溶性粉剂制备方法及应用
CN1751577A (zh) 一种含银、锌复合型杀菌剂及其制备方法与应用
JP2018508523A5 (cg-RX-API-DMAC7.html)
RU2018111436A (ru) Композиция для поддержания доминирования лактобактерий
SI2968442T1 (en) New stable pentadecapeptide salts, a process for their preparation, their use in the manufacture of pharmaceutical preparations and their use in therapy
JP6072516B2 (ja) アレルギー改善剤
JP2015522040A5 (cg-RX-API-DMAC7.html)
US8647635B2 (en) Compositions comprising red microalgae polysaccharides and metals
RU2017114677A (ru) Перорально распадающаяся твердая фармацевтическая единица дозирования, содержащая контролирующее родовую деятельность вещество
CN101444514A (zh) 一种注射用盐酸头孢甲肟制剂及其制备方法
BR112020026976A2 (pt) produto combinado e complexo para potencializarem uma resposta imune, uso do complexo, composição de vacina e composição farmacêutica, método que promove resposta imune in vivo a um antígeno em um hospedeiro
JP2025522924A (ja) 薬物送達用バイオポリマー製剤
CN111358813B (zh) 一种用于保护呼吸道的盐雾混合物
CN103301117A (zh) 注射用盐酸氨溴索组合物